» Articles » PMID: 28098828

Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2017 Jan 19
PMID 28098828
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol (RSV) is well known for its anti-oxidant and anti-aging properties. However, resveratrol is insoluble in water and has stability issues. Recently, efforts were placed to prepare a resveratrol-based advanced anti-aging topical product but it contains harsh organic solvents and oils that could be harmful to the human body and the environment. Hence, we propose the use of a multifunctional dendrimer to solve the solubility and stability issues of resveratrol. A dendrimer-resveratrol complex was prepared, optimized and tested for solubility enhancement, stability in solution and cream dosage forms. We have also developed a high performance liquid chromatography method to measure the resveratrol within the final product. PAMAM dendrimers increased the solubility and stability of resveratrol in water and semisolid dosage forms. Therefore, this product would be water based 'green' formulation devoid of harsh organic solvents and oils and can be safely applied to the skin. Additionally, we have shown that the dendrimer helped to increase overall RSV loading and skin penetration of resveratrol. The dendrimer-RSV formulation was successfully scaled up towards commercialization. Dendrimer with RSV has led to an innovation in anti-aging cream and solutions that could be commercially marketed. Dendrimer-RSV complex could also be added to other product forms for additional purposes and applications.

Citing Articles

Development and Characterization of Novel Combinations and Compositions of Nanostructured Lipid Carrier Formulations Loaded with Trans-Resveratrol for Pulmonary Drug Delivery.

Khan I, Sunita S, Hussein N, Omer H, Elhissi A, Houacine C Pharmaceutics. 2025; 16(12.

PMID: 39771567 PMC: 11677727. DOI: 10.3390/pharmaceutics16121589.


Nano-based drug delivery systems for active ingredients from traditional Chinese medicine: Harnessing the power of nanotechnology.

Zhang Y, Wang J, Wang M, Peng J, Kong X, Tian J Front Pharmacol. 2024; 15:1405252.

PMID: 38910887 PMC: 11190311. DOI: 10.3389/fphar.2024.1405252.


Piceid Octanoate Protects Retinal Cells against Oxidative Damage by Regulating the Sirtuin 1/Poly-ADP-Ribose Polymerase 1 Axis In Vitro and in rd10 Mice.

Moshtaghion S, Caballano-Infantes E, Plaza Reyes A, Valdes-Sanchez L, Fernandez P, de la Cerda B Antioxidants (Basel). 2024; 13(2).

PMID: 38397799 PMC: 10886367. DOI: 10.3390/antiox13020201.


A Molecular Dynamics Simulation of Complexes of Fullerenes and Lysine-Based Peptide Dendrimers with and without Glycine Spacers.

Bezrodnyi V, Mikhtaniuk S, Shavykin O, Sheveleva N, Markelov D, Neelov I Int J Mol Sci. 2024; 25(2).

PMID: 38255765 PMC: 10815860. DOI: 10.3390/ijms25020691.


Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review.

Won S, An J, Song H, Im S, You G, Lee S Front Neurosci. 2023; 17:1137096.

PMID: 37292158 PMC: 10246499. DOI: 10.3389/fnins.2023.1137096.


References
1.
Chauhan A, Sridevi S, Chalasani K, Jain A, Jain S, Jain N . Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release. 2003; 90(3):335-43. DOI: 10.1016/s0168-3659(03)00200-1. View

2.
Esfand R, Tomalia D . Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001; 6(8):427-436. DOI: 10.1016/s1359-6446(01)01757-3. View

3.
Chauhan A . Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol. Ann N Y Acad Sci. 2015; 1348(1):134-40. DOI: 10.1111/nyas.12816. View

4.
Alarcon de La Lastra C, Villegas I . Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans. 2007; 35(Pt 5):1156-60. DOI: 10.1042/BST0351156. View

5.
Kulhari H, Pooja D, Prajapati S, Chauhan A . Performance evaluation of PAMAM dendrimer based simvastatin formulations. Int J Pharm. 2010; 405(1-2):203-9. DOI: 10.1016/j.ijpharm.2010.12.002. View